In vivo assessment of GABAergic inhibition and glutamate facilitation in treatment-resistant schizophrenia: a TMS study integrating clinical, cognitive, and neurophysiological evaluations.
- DOI
- 10.1038/s41537-025-00634-w
- Published
- 2025 Jun 19
- Container
- Schizophrenia (Heidelberg, Germany)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41537-025-00634-w,
title = {In vivo assessment of GABAergic inhibition and glutamate facilitation in treatment-resistant schizophrenia: a TMS study integrating clinical, cognitive, and neurophysiological evaluations.},
author = {Barone A and Senerchia G and De Simone G and Manzo M and Ciccarelli M and Tozza S and Iuzzolino VV and Spisto M and Dubbioso R and Iasevoli F and Iodice R and de Bartolomeis A},
year = {2025},
journal = {Schizophrenia (Heidelberg, Germany)},
doi = {10.1038/s41537-025-00634-w},
url = {https://doi.org/10.1038/s41537-025-00634-w}
}RIS
TY - JOUR TI - In vivo assessment of GABAergic inhibition and glutamate facilitation in treatment-resistant schizophrenia: a TMS study integrating clinical, cognitive, and neurophysiological evaluations. AU - Barone A AU - Senerchia G AU - De Simone G AU - Manzo M AU - Ciccarelli M AU - Tozza S AU - Iuzzolino VV AU - Spisto M AU - Dubbioso R AU - Iasevoli F AU - Iodice R AU - de Bartolomeis A PY - 2025 JO - Schizophrenia (Heidelberg, Germany) DO - 10.1038/s41537-025-00634-w UR - https://doi.org/10.1038/s41537-025-00634-w ER -
APA
A, B., G, S., G, D. S., M, M., M, C., S, T., VV, I., M, S., R, D., F, I., R, I., & A, D. B. (2025). In vivo assessment of GABAergic inhibition and glutamate facilitation in treatment-resistant schizophrenia: a TMS study integrating clinical, cognitive, and neurophysiological evaluations.. Schizophrenia (Heidelberg, Germany). https://doi.org/10.1038/s41537-025-00634-w
Source records
- pubmed · retrieved 2026-09-26T06:31:17.150Z